SC-44942A

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSC-44942A
Drug Alias NameSC-44942A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsProtozoan InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsProtozoan InfectionsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A